X-120376413-G-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001142447.3(ATP1B4):āc.793G>Cā(p.Val265Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0000364 in 1,208,846 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 25 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000036 ( 0 hom., 3 hem., cov: 23)
Exomes š: 0.000036 ( 0 hom. 22 hem. )
Consequence
ATP1B4
NM_001142447.3 missense
NM_001142447.3 missense
Scores
1
5
11
Clinical Significance
Conservation
PhyloP100: 5.36
Genes affected
ATP1B4 (HGNC:808): (ATPase Na+/K+ transporting family member beta 4) This gene has been found in all vertebrate genomes sequenced to date. However, this gene has undergone a change in function in placental mammals compared to other species. Specifically, in fish, avian, and amphibian species, this gene encodes plasma membrane-bound beta-subunits of Na,K-ATPase. In placental mammals, the encoded protein interacts with the nuclear transcriptional coregulator SKIP and may be involved in the regulation of TGF-beta signaling. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.121397495).
BS2
High Hemizygotes in GnomAd4 at 3 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATP1B4 | NM_001142447.3 | c.793G>C | p.Val265Leu | missense_variant | 6/8 | ENST00000218008.8 | NP_001135919.1 | |
ATP1B4 | NM_012069.5 | c.781G>C | p.Val261Leu | missense_variant | 6/8 | NP_036201.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATP1B4 | ENST00000218008.8 | c.793G>C | p.Val265Leu | missense_variant | 6/8 | 1 | NM_001142447.3 | ENSP00000218008 | P1 | |
ATP1B4 | ENST00000361319.3 | c.781G>C | p.Val261Leu | missense_variant | 6/8 | 1 | ENSP00000355346 | |||
ATP1B4 | ENST00000539306.5 | c.664G>C | p.Val222Leu | missense_variant | 5/7 | 2 | ENSP00000443334 |
Frequencies
GnomAD3 genomes AF: 0.0000357 AC: 4AN: 112050Hom.: 0 Cov.: 23 AF XY: 0.0000877 AC XY: 3AN XY: 34216
GnomAD3 genomes
AF:
AC:
4
AN:
112050
Hom.:
Cov.:
23
AF XY:
AC XY:
3
AN XY:
34216
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000547 AC: 10AN: 182971Hom.: 0 AF XY: 0.0000593 AC XY: 4AN XY: 67461
GnomAD3 exomes
AF:
AC:
10
AN:
182971
Hom.:
AF XY:
AC XY:
4
AN XY:
67461
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000365 AC: 40AN: 1096796Hom.: 0 Cov.: 29 AF XY: 0.0000607 AC XY: 22AN XY: 362202
GnomAD4 exome
AF:
AC:
40
AN:
1096796
Hom.:
Cov.:
29
AF XY:
AC XY:
22
AN XY:
362202
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000357 AC: 4AN: 112050Hom.: 0 Cov.: 23 AF XY: 0.0000877 AC XY: 3AN XY: 34216
GnomAD4 genome
AF:
AC:
4
AN:
112050
Hom.:
Cov.:
23
AF XY:
AC XY:
3
AN XY:
34216
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
8
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 08, 2023 | The c.793G>C (p.V265L) alteration is located in exon 6 (coding exon 6) of the ATP1B4 gene. This alteration results from a G to C substitution at nucleotide position 793, causing the valine (V) at amino acid position 265 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;.
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T;T
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;L;.
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Benign
T;T;T
Sift4G
Benign
T;T;T
Polyphen
B;B;B
Vest4
MutPred
0.62
.;Loss of ubiquitination at K270 (P = 0.0896);.;
MVP
MPC
0.37
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at